| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 107.124 | 97.914 | 151.169 | 191.959 | 201.893 | 245.262 | 223.114 | 222.069 | 200.413 | 205.964 |
| Total Income - EUR | 107.140 | 98.264 | 151.445 | 193.363 | 202.263 | 245.283 | 223.490 | 222.105 | 200.420 | 205.965 |
| Total Expenses - EUR | 100.862 | 86.946 | 118.860 | 162.428 | 186.335 | 212.214 | 208.786 | 280.429 | 181.594 | 182.975 |
| Gross Profit/Loss - EUR | 6.278 | 11.318 | 32.585 | 30.935 | 15.928 | 33.070 | 14.705 | -58.324 | 18.825 | 22.991 |
| Net Profit/Loss - EUR | 5.422 | 9.507 | 30.673 | 29.002 | 13.905 | 30.617 | 12.473 | -60.545 | 16.819 | 19.097 |
| Employees | 0 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Biocondruz Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 12.329 | 10.101 | 396 | 0 | 535 | 487 | 299 | 0 | 0 | 0 |
| Current Assets | 50.796 | 70.736 | 120.095 | 148.214 | 152.561 | 179.482 | 194.864 | 143.941 | 158.353 | 189.179 |
| Inventories | 51.252 | 69.809 | 112.909 | 143.281 | 157.825 | 188.424 | 200.700 | 146.480 | 164.891 | 189.217 |
| Receivables | 3.148 | 2.177 | 1.380 | 848 | 0 | 992 | 1.141 | 7.906 | 3.357 | 4.232 |
| Cash | -3.603 | -1.250 | 5.807 | 4.084 | -5.264 | -9.934 | -6.978 | -10.445 | -9.895 | -4.270 |
| Shareholders Funds | 30.943 | 40.135 | 70.129 | 93.569 | 105.662 | 134.276 | 143.772 | 87.045 | 103.600 | 122.342 |
| Social Capital | 112 | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 32.182 | 40.702 | 50.363 | 54.644 | 47.434 | 45.692 | 51.391 | 56.896 | 54.753 | 66.837 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4752 - 4752" | |||||||||
| CAEN Financial Year |
4752
|
|||||||||
Comments - Biocondruz Srl